Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $35.12 in the last session, up 4.03% from day before closing price of $33.76. In other words, the price has increased by $4.03 from its previous closing price. On the day, 0.62 million shares were traded. KYMR stock price reached its highest trading level at $35.57 during the session, while it also had its lowest trading level at $33.67.
Ratios:
We take a closer look at KYMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.73 and its Current Ratio is at 4.73. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
BofA Securities Downgraded its Buy to Neutral on January 03, 2024, whereas the target price for the stock was revised from $45 to $30.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 15 ’24 when Booth Bruce sold 71,764 shares for $40.46 per share. The transaction valued at 2,903,336 led to the insider holds 806,697 shares of the business.
Booth Bruce sold 55,779 shares of KYMR for $2,229,927 on Mar 14 ’24. The Director now owns 819,151 shares after completing the transaction at $39.98 per share. On Mar 13 ’24, another insider, Booth Bruce, who serves as the Director of the company, sold 139,255 shares for $42.23 each. As a result, the insider received 5,880,415 and left with 828,830 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2146242816 and an Enterprise Value of 1856035072. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.31 while its Price-to-Book (P/B) ratio in mrq is 4.94. Its current Enterprise Value per Revenue stands at 23.616 whereas that against EBITDA is -11.354.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $45.31, while it has fallen to a 52-week low of $9.60. The 50-Day Moving Average of the stock is -9.92%, while the 200-Day Moving Average is calculated to be 39.18%.
Shares Statistics:
According to the various share statistics, KYMR traded on average about 671.67K shares per day over the past 3-months and 501820 shares per day over the past 10 days. A total of 55.59M shares are outstanding, with a floating share count of 54.16M. Insiders hold about 11.38% of the company’s shares, while institutions hold 90.17% stake in the company. Shares short for KYMR as of 1711584000 were 9061908 with a Short Ratio of 13.49, compared to 1709164800 on 8247519. Therefore, it implies a Short% of Shares Outstanding of 9061908 and a Short% of Float of 16.620001000000002.
Earnings Estimates
A detailed examination of Kymera Therapeutics Inc (KYMR) is currently in progress, with Kymera Therapeutics, Inc. analysts providing valuable insights into its market dynamics.
